Another pharmacy recalls products in meningitis cases
- Ameridose voluntarily recalls all its products
- Company tied to firm blamed for meningitis outbreak
- Tainted drugs linked to 29 deaths, 11 in Tennessee
A Massachusetts drug firm linked by common ownership to the company blamed for an ongoing nationwide meningitis outbreak has announced a massive recall of all its products.
In a statement released today, Ameridose disclosed that it had initiated a voluntary recall of all its products.
Ameridose is owned by the same two families that own New England Compounding Center, which issued thousands of doses of a spinal steroid tainted with fungus. The drugs are linked to 29 deaths.
The Centers for Disease Control and Prevention reported on Wednesday 377 illnesses, including nine joint infections. Nineteen states are affected.
In announcing the recall, Ameridose said that it came after the U.S. Food and Drug Administration raised questions about the company's sterility testing process. Ameridose, which supplies hospitals in Tennessee, already had halted production at its Westborough, Mass., plant.
"This action is voluntary and represents an expansion of our cooperation with the FDA and the Massachusetts Board of Registration in Pharmacy," the company stated.
"Ameridose has not received any adverse reports related to the products subject to this recall and neither Ameridose nor the FDA has identified impurities in any Ameridose products," the statement continued.
Contributing: Associated Press